Skip to content

uniQure QURE Interest Paid

Interest Paid at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$23.42M+226%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.45M+11.8%
Precigen logo
PrecigenPGEN
$2.56M
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.16M0.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$1.12M+150%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's interest paid?
uniQure (QURE) reported interest paid of $6.72M in Q1 2026.
How has uniQure's interest paid changed year-over-year?
uniQure's interest paid increased by 3.5% year-over-year, from $6.49M to $6.72M.
What is the long-term trend for uniQure's interest paid?
Over 4 years (2021 to 2025), uniQure's interest paid has grown at a 39.9% compound annual growth rate (CAGR), from $6.54M to $25.07M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.